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The result of applying the Neurite Orientation Density and Dispersion Index 
(NODDI) algorithm to improve the prediction accuracy for patients diagnosed with 
MCI is reported. Calculations were carried out using a collection of 68 patients (34 
control and 34 with MCI) gathered from the Alzheimer’s Disease Neuroimaging 
Initiative database (ADNI). Patient data includes the use of high-resolution 
Magnetic Resonance Images as with as Diffusion Tensor Imaging. A Linear 
Regression accuracy of 83% was observed using the added NODDI summary 
statistic: Orientation Dispersion Index (ODI). A statistically significant difference 
in groups was found between control patients and patients with MCI with a power 
0.96. In order to confirm performance, comparison of accuracy of prediction 
without the use and with the use of the ODI values is also presented. The impact of 
this increase in accuracy on the early detection of MCI is also presented. Results 
show a 4.68% increase in prediction accuracy through the inclusion of the ODI 
values. Future work includes the use of tractography to better locate the specific 
area of interest. Increasing the cohort would also add validity to the results in this 
paper. Expanding the number of tracts utilized in this study would also validate the 
use of the NODDI algorithm to detect neurological deterioration in tracts 
associated with memory. The inclusion of more complex prediction models would 
also add possible increases in performance in modeling patients with MCI.  
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Mild Cognitive Impairment is defined as cognitive dysfunction without functional 
disability and this entity is believed to be an early stage of degenerative brain 
disorder that progresses to dementia. Dementia is a syndrome characterized by 
cognitive decline in one or more areas of cognition including memory and that 
cognitive decline must be characterized as being enough to interfere functioning, 
activities necessary to conduct the day to day life of the patient (Jalbert, Daiello, & 
Lapane, 2008; Lyketsos et al., 2006). Dementia can result from a spectrum of brain 
diseases that include Alzheimer’s Disease, vascular dementia, Parkinson’s dementia, 
all of which have cognitive and functional disability.  
Alzheimer’s Disease (AD) is a fatal disease defined as the global deterioration of 
memory and other cognitive domain (Jalbert et al., 2008). The prevalence of 
Alzheimer’s tends to increase with age with an occurrence of 1 in 1,000 people 
between the age of 60-64 and 25 per 1,000 for those above the age of 85 developing 
the disease (Jalbert et al., 2008; van Duijn, 1996). 1 to 2 percent of healthy adults 
progress to developing Alzheimer’s Disease each year (Bischkopf, Busse, & 
Angermeyer, 2002). For patients with Mild Cognitive Impairment the chance of 
conversion is much higher at 10 to 15 percent per year (Bischkopf et al., 2002; 
Knopman & Petersen, 2014). 
Mild Cognitive Impairment (MCI), as opposed to Alzheimer’s, is more subtle. MCI 
is defined as an in-between state where the patient has cognitive limitations but 
functionality is generally intact but there may be subtle difficulties in functioning. 
This distinction does not lie under the definition of dementia, but still remains to 
inhibit the patient’s day to day life (Petersen, Doody, et al., 2001; Petersen, Stevens, 
et al., 2001; Rivas-Vazquez, Mendez, Rey, & Carrazana, 2004). The general criteria 
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for the diagnosis of MCI can be broken down into 5 points taken from Petersen et 
al. (1999):  
• Patient reports complaints of memory issues, which would be corroborated by 
a trusted third-party.  
• Difference from the age norm of 1.5 standard deviations on a memory 
impairment test. 
• No other issues in cognitive functioning. 
• Does not meet the criteria for Dementia.  
• Ability to perform day-to-day functioning including driving a car.  
Mild Cognitive Impairment and Alzheimer’s Disease currently affect 16 million and 
5.1 million people world-wide respectively. The number patients diagnosed with 
Alzheimer's disease is estimated to rise to 13.2 million by 2020 and according to 
Brookmeyer, Johnson, Ziegler-Graham, and Arrighi (2007) by 2050 1 in 85 people 
will be living with Alzheimer’s disease. This increase can be reduced through the 
practice of early detection and therapies. If early intervention can cause a 1 year 
decrease in the onset of the disease an estimated 9.2 million fewer cases will occur 
by the year 2050 (Brookmeyer et al., 2007). 
Current best practices for diagnosing MCI in a clinical setting involves conducting 
a thorough assessment of a subject’s overall physical and cognitive health (Albert et 
al., 2011). This includes a number of examinations primarily focused on excluding 
alternative diagnoses through a review of a patient’s medical history, diagnostic 
questionnaires, and cognitive evaluation (Neugroschl & Wang, 2011). The most 
common early difficulty is memory dysfunction. One of the most challenging and 
sensitive measures is list learning and the most commonly used measure is the 
RAVLT (Rabin et al., 2009). Ultimately as AD progresses other cognitive domains 
are involved and a screening measure such as the Montreal Cognitive Assessment 
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(MoCA). Although short, it is used to describe the severity of dementia and surveys 
multiple cognitive domains. These measures include items sensitive for memory and 
hence can be used to detect MCI but is relatively less sensitive to memory 
dysfunction than RAVLT. Whereas there is a general consistency in the types of 
information leading to a diagnosis, not all people with symptoms of MCI progress 
to AD and hence additional imaging and other biomarker data are being incorporated 
in research diagnosis with the goal of clinical use.  
One approach to improving the early detection of preclinical AD is to focus detecting 
the earliest degenerative changes in the medial temporal lobe (MTL). This region is 
responsible for memory. Previous studies have demonstrated correlations between 
memory ability and MRI volume (Moradi, Hallikainen, Hanninen, Tohka, & 
Alzheimer's Disease Neuroimaging, 2017). Because AD degeneration is 
progressive, one would expect that there would be longitudinal change in the 
structural differences between MCI and healthy older adults.  
Combining minimally invasive neuroimage-based measures of localized structural 
changes in the brain over time with other cognitive measures appears promising as 
the basis of a more effective MCI diagnostic approach than is currently available. 
This lack of combination in the field provides us with a technical gap in the current 
literature that we wish to address in this report. Whereas there have been multiple 
studies of MTL atrophy, white matter changes in the MTL have not been extensively 
studied (Goldman et al., 2017; Wen et al., 2019). 
Neuroimage-based analysis includes the use of systems that that model the 
intricacies of the brain’s internal structure and architecture. From these models, 
summary statistics are generated. These statistics are then used to further analyze 
group differences. One such analysis presented in this report is Neurite Orientation 
Density and Dispersion Index (NODDI). NODDI produces a summary statistic that 
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characterizes the orientation dispersion of axon bundles. Analysis from NODDI 
utilizes shape distributions that closely resembles the shape and make up different 
types of tissues found in the brain. The analysis and application of this algorithm is 
presented in this report.  
BACKGROUND 
The brain changes of AD appear about a decade before the symptoms appear. MCI 
is a transition stage when there is cognitive dysfunction detectable by 
neuropsychological testing but before the progression to the disabling functional 
incapacity of Alzheimer’s dementia (Bateman et al., 2012; Golomb, Kluger, & 
Ferris, 2004; Roberts et al., 2014). During this period the brains of people with 
neuropathology is deteriorating at a rate greater than those with healthy brains. 
Diagnosing at or before the complete deterioration of the brain is important to the 
longevity of the patient and the impact on the medical system (Brookmeyer et al., 
2007).  
Clinical Diagnosis 
The current clinical diagnostic criteria for Mild Cognitive Impairment primarily 
focuses on whether the patient experiences cognitive declines but functional 
decline in everyday life is minimal (Albert et al., 2011). Examples of difficulty 
functioning include writing checks, shopping alone, playing a game, making a cup 
of coffee, etc. and whether these tasks have been inhibited by any sort of memory 
issue (Pfeffer, Kurosaki, Harrah, Chance, & Filos, 1982; Teng et al., 2010). 
Neuropsychological tests are critical for diagnosis. Whereas memory is typically 
the earliest symptom of AD, other cognitive domains can be diminished including 
language, attention and mental control, and visuospatial functioning.  
A variety of paper and pencil neuropsychological tests are typically used. One such 
test which this project utilizes is Rey Auditory Verbal Learning Test, or RAVLT 
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(Schmidt, 1996). RAVLT, originally created by Andre Rey, a Swiss psychologist, 
was developed to assess verbal memory in patients 16 and older. RAVTL has 
shown through multiple studies to play a significant role in the early detection of 
early onset  Alzheimer’s (Estevez-Gonzalez, Kulisevsky, Boltes, Otermin, & 
Garcia-Sanchez, 2003; Moradi et al., 2017). Brain volume has also shown to be a 
predictor of a patients RAVLT  score with a has been shown to be a predictor for 
brain volume as detailed by Moradi et al. (2017). For more information regarding 
the intricacies of RAVLT and how it is run please refer to Appendix A.  
The second test considered in this project is MoCA or Montreal Cognitive 
Assessment. MoCA, created in 1996 by Ziad Nasreddine, a Canadian neurologist, 
was specially designed for the early detection of Alzheimer’s (Neugroschl & 
Wang, 2011) and has shown to be a highly sensitive screening measure that briefly 
surveys multiple cognitive domains including memory (Nasreddine et al., 2005). 
Whereas memory decline is the most common domain affected early in AD, in 
some subtypes of AD other domains are affected hence a global screening measure 
is an important additional measure. Because AD patients often lack insight into 
their functional difficulties and have deficits in several domains, a score on MoCA 
that is too low is also a warning sign that the patient has progressed beyond the 
stage of MCI to AD. For more information regarding the cut offs and ranges of 
different stages, please refer to Appendix B. 
Diagnosis Using Neuroimaging 
Although these tests have shown to be decent predictors of future progression to 
AD, they exhibit high rate of false positives, which warrants exploring other 
options for diagnostic tests. Having convergent data from neuroimaging can 
increase accuracy of the diagnosis. Historically clinicians relied on postmortem 
analysis to identify the AD brain pathology; however, presently PET identifies 
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both tau and amyloid pathology. Another such technology is Magnetic Resonance 
Images (MRI) which has the advantage of not requiring injection of radioactive 
tracers like PET. MRI uses powerful magnets to change the direction of spin of 
hydrogen atoms in the patient’s bodies. Some of the hydrogen atoms will align to 
the new magnetic direction imposed. Of these newly facing directions exist some 
hydrogen atoms that face in opposing directions to their local space’s magnetic 
direction. This change in direction is then interrupted using powerful radio signals 
which then causes these standouts to align back to the herd’s original direction. 
This sudden change releases energy which is then read by the detector facing the 
patient. The energy is then converted to digital images. These images provide a key 
point in the examination of the flow of water in the brain of the patient. Depending 
on the way the MRI is created, different brain tissues have different values, 
displayed to clinician as brightness or intensities. This information is clinically 
important and can be compared to learn about the locations of the brain and 
integrity of its functioning. With sophisticated analytic techniques that compare the 
locations of the brain both within and across, information researchers can derive 
additional insights.  
This project relies on two types of images: structural T1 weighted images, and a 
Diffusion Weighted Image (DWI). On a structural, T1 image, the surface of the 
brain (cortex, grey matter) is grey and underneath the cortex the brain appears 
white (denoted white matter). This difference in intensity is critical information 
about the role of those brain regions. Information regarding grey and white matter 
can be found in Appendix C.  
Diffusion Weighted Images are a different kind of image that instead is sensitive to 
white matter tracts. Typically, white matter is organized as groups of axons or 
fibers tracts and to the extent those fibers are healthy/intact and/or the brain region 
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that DWI will vary in intensity. The technique depends on the fact that DWI is 
sensitive to the degree to which water diffuses along these axons or fiber tracts. 
Variation in diffusivity can be thought of conceptually as water moving along a 
straw. Movement on the outside of the straw is unrestricted this is coined as “Free 
Diffusion”. Much like the walls of a straw, water does not diffuse from the outside 
to the inside of the straw. DWI thus generates an image that varies in Free 
Diffusion and Diffusion Restriction. Included with this image is two metadata 
points that characterize the gradient’s strength and timing at the moment of 
acquisition; this is included as a “b-value”. The gradient directions at said time is 
also included as a “b-vector”. An example of such an image can be seen in Figure 
1. The image contains a processed Diffusion Weighted Image. Areas of diffusion 
restriction are indicated through bright white intensities, whereas areas with less 




Figure 1: Diffusion Weighted Image Example 
Free diffusion is shown as bright white spots on the image and indicates the ability 
for water in that sector to freely diffuses in any direction. Conversely, diffusion 
restriction indicates limited diffusion in that area and as a result the intensity is 
lower.  
The field studying AD has focused on measuring grey matter volume, typically in 
the hippocampus and related medial temporal lobe (MTL) structures and less so on 
white matter fiber tract degeneration, hence DWI has been less frequently applied 
in the prediction of MCI/Alzheimer’s (Miller et al., 2015). 
Whereas DWI represents brain locations in terms of their diffusivity, to represent 
fiber tracts involves complex analyses. Diffusion Tensor Imaging (DTI) is a 
method of analysis that uses water diffusion to map, detect, and detail tracts of 
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axons, the long, glia encased fibers that connect the bodies of neurons (grey 
matter).  
Diffusion Tensor Imaging 
DTI analysis was originally proposed by Peter Basser (Basser, Mattiello, & 
LeBihan, 1994a, 1994b) and relies on the concept of a diffusion tensor. An image 
analyzed by Diffusion Tensor Imaging contains a multitude of points called voxels 
(or volumes in 3d space). Each of these voxels in the brain model either one of 
three types of tissues in the brain: white matter, grey matter, and cerebral spinal 
fluid. DTI analysis of these voxels provide a general model of inherent 
characteristics of the tissue analyzed. In-order to produce this general model a 
series of processing steps needs to occur and, depending on the source of data, can 
be prone to errors as a result much preprocessing needs to take place (Soares, 
Marques, Alves, & Sousa, 2013). These steps are detailed later in the Methods 
section. More information regarding the background of diffusion tensor imaging is 
included in Appendix D. 
Diffusion Tensor Imaging’s main parameters: Mean Diffusivity (MD) and 
Fractional Anisotropy (FA) have seen use in predicting atrophy among patients 
along the spectrum of degeneration. Selnes et al. (2013) utilizes DTI in a way to 
further predict, using regression, atrophy among patients with subjective and mild 
cognitive impairment. Selnes et al. (2013) found, through a targeted study in the 
medial temporal lobe, that MD and FA were significantly associated with atrophy 
(p < 0.05). For the regression analysis, MD was found to be able to predict atrophy 
whereas FA was not.   
In Bozzali et al. (2002) FA was found to be a statistically significant difference 
between the controls and AD group (p < 0.01). The areas of interest that produced 
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the lowest p value includes: the corpus callosum, frontal, temporal, and parietal 
lobe.  
Although these statistics have seen wide use, DTI is not without its pitfalls. There 
is a general recognition that in brain locations where postmortem dissection 
identifies that densely packed fiber tracts cross or axonal bundles join, the results 
of analysis conducted in these areas are ambiguous. Because DTI works on a voxel 
per voxel basis these overlaps hinder the analysis of Fractional Anisotropy 
(Tournier, Mori, & Leemans, 2011).  
Technical Gaps 
When using DTI models, a lot of key information is lost through its ambiguity. In-
order to address this difference in tissue modeling a multi model method must be 
used, one for each type of tissue. This multi model method, otherwise known as 
Diffusion Compartmental Imaging, provides a deeper insight into those regions 
that might be hindered through a flat analysis of the entirety of the brain. To close 
this technical gap, we utilize this method in conjunction with available cognitive 
tests including RAVLT and MoCA to provide a robust implementation. For more 
information and background regarding Diffusion Compartment Imaging please 
refer to Appendix E. 
APPROACH 
Data 
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) database founded by 
Principle Investigator Michael W. Weiner, MD in 2003 was the primary supplier of 
Data utilized in this project. The supplied data contains that of a multitude of 
mediums including Magnetic Resonance Imaging (MRI), clinical assessments, 
neuropsychological assessments, Positron Emission Tomography (PET), and 
biological markers. The intent of the project is to test the viability of these mediums 
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in the pursuit of measuring the progression of Mild Cognitive Impairment (MCI) 
and early Alzheimer’s disease (AD).  
The database acts as a hub for a variety of studies related to Alzheimer’s and contains 
several patients who are on the spectrum between normal cognition (NC) and 
dementia.  
The database is primarily broken up into 4 participant stages 1, GO, 2, and 3 with 3 
being the focus of attention for this project. ADNI3 is the latest in the line of studies 
starting from 2016 onward and concluding in 2022. This cohort includes several 
patients including 133 elderly controls, 151 patients with MCI, and 87 patients with 
Alzheimer’s disease.  
Included in the ADNI study are a wide variety of imaging types. Of those types this 
project focuses on two types: Structural and Diffusion Imaging.  
Structural Imaging 
The primary purpose of Structure Imaging (T1) is to visualize the entirety of the 
brain and produce clear delineation of tissue types. This includes highly detailed and 
highly contrasted images that convey the internal structures of the brain. The primary 
way of acquiring this structural imaging is with magnetic resonance imaging (MRI). 
This type of imaging includes T1 and T2-weighted images.  Our study primarily 
focused on T1 images. This type of imaging removes variations in the resulting 
image of the brain and provides a high amount of resolution for clearer analysis (M 
Symms et. al.).  
The use of this type of image in our methods provides for a greater ability to segment 
portions of the brain known as white matter, grey matter, and cerebrospinal fluid 
(CSF). Through this we can clearly see the differentiation between the three and as 
such generate masks related to these areas. As detailed in our analysis methods, this 
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is a pivotal implementation that gives us the ability to extract out a specific portion 
of the brain for use in the later analysis. Specific to the T1 image utilized, we focused 
on using ones generated through the 3D Magnetization-prepared rapid gradient-echo 
(MPRAGE) sequence. MPRAGE has shown to be well-established across studies 
over a period as well as studies that occur at different sites or labs (Falkovskiy et. 
Al). MRPAGE also provides high contrast which allows for a clearer differentiation 
between tissues (Falkovskiy et. Al).  
Diffusion Imaging is the prime focus for this project and provides the underlying 
data that is operated on in order to produce our summary statistic. Diffusion Imaging 
is a technique used to measure the diffusion of water through the brain. This 
diffusion details the motion of water molecules present in the brain. Through this 
information we can identify the direction of this flow using a variety of techniques. 
Cohort 
The cohort analyzed consists of 34 control subjects and 34 patients diagnosed with 
mild cognitive impairment. Each diagnosis of the patients was taken directly from 
the ADNI3 dataset and were the result of a consensus diagnosis of experts.  
Of this cohort, the distribution of age acted as a nuisance parameter for the analysis 
of whose distribution is referenced in Figure 1. The distribution of controls 




Figure 2: Age Distribution of ADNI3 Patients 
The cohort also consists of a minimum of two time-series data points. Two runs 





Figure 3: (a) MOCA score Distribution at time 0 (b) MOCA score Distribution at time 1 (c) RAVLT immediate score Distribution 
at time 0 (d) RAVLT immediate score Distribution at time 1 
 
The analysis utilized in this study is the previously described Diffusion 
Compartmental Imaging (DCI). The specific algorithm utilized is Neurite 
Orientation Dispersion and Density Imaging (NODDI). This method was used in 
conjunction with a large number of data pre-processing and manipulation steps, 
which utilize the FMRIB Software Library (FSL). FSL includes several packages 
that help in the processing and analysis of MRI data. Among those packages 
included, this project specifically utilized seven: fslreorient2std, BET, eddy_correct, 
flirt, fast, fslsplit, and fslmaths.  




Figure 4: General Analysis Pipeline 
The entirety of the pipeline is broken down into three sections. The first step includes 
the preprocessing and formatting of the patient data. This includes the following FSL 
packages: fslreorient2std, bet, eddy_correct, and flirt. The second step, being the run 
of NODDI on the pre-processed patient’s data. The last being the post-processing 
step that includes the use of a variety of masking tooks such as: fslmaths and 




The goal of this preprocessing step is to fulfill the preconditions for the analysis. The 
first condition is that the patient’s data be registered correctly to MNI space. This 
space refers to a known orientation and coordinate system generated from an average 
of 152 images of human brains. This registration allows for the targeted analysis of 
specific portions of the brain using known coordinates. The template used in this 
stage is the MNI 152 average template (Brett, Johnsrude, & Owen, 2002) included 
in the default FSL data. 
The first step of this four-step process is to utilize the fslreorient2std tool. This tool 
acts as a simple reorientation script to the MNI 152 template. It reorients it in such  
a way that the brain is in the same orientation in the left and the right space and is 
directly on top of the MNI template. This allows for a registration process that is 
least error prone.  
The second step is to utilize the BET tool also included in FSL. BET is a simple 
brain extraction tool. From patients MRI and DTI, it produces an image that only 
includes the actual brain itself. This is used to exclude parts of the image included 
in the raw base image of the patient’s brain. These parts might include the outer 
portion of the skull, the eyes, and any other part outside the scope of interest. This 
result is the stripped image and is then fed into the next stage: eddy_correct. 
Eddy_correct or simply eddy, is a tool for use in the correction of eddy current-
induced distortions and subject movements for diffusion imaging (Andersson & 
Sotiropoulos, 2016). This tool allows for the correction of possible imperfect 
acquisitions of patient’s brains during the process of collecting the diffusion of water 
molecules in the brain (DTI). It “corrects for distortions by registering the individual 
models to a model free prediction of what each volume should look like” (Andersson 
& Sotiropoulos, 2016). These corrections allow for the use of images that would 
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otherwise be error prone due to issues at the collection stage. After this stage is 
complete the results are then fed to the registration stage. 
The tool used for this registration stage is the flirt tool supplied by FSL (Jenkinson 
& Smith, 2001) (Jenkinson, Bannister, Brady, & Smith, 2002). Flirt or FMRIB’s 
Linear Image Registration Tool is a tool for automatic linear brain image 
registration. Image registration is the process with which one image is transformed 
from its coordinate space to another images coordinate space. This is the key point 
of this section. The registration of the DTI and MRI image puts them both into “MNI 
space”. MNI space is a well-known probabilistic atlas developed at the Montreal 
Neurological Institute. Individual brains are reshaped or warped to match the atlas 
so that overlaying them increases the likelihood that functional areas align. With this 
transformation images can be analyzed together in voxel-based space rather than by 
manual tracing base on the shape of different brain regions. 
The atlas has been used to derive a vast number of masks or clusters of voxels that 
align with prior defined brain regions. These masks can be multiplied by whole brain 
images to select these regions. For example, with a binary mask in which the target 
brain voxels have the value of 1 and non-target brain regions have the value of 0, a 
multiplication of these images selects the target brain region eliminating all other 
regions. This masking is one of the reasons for this pre-processing step as detailed 
in the post-processing step. Having both images also registered in this space allows 
for a consistent analysis across cohorts as all the images of the brains in this cohort 
have been transformed into a common space. Once transformed the cohort’s brains 
can then be reliably compared knowing that the sample space each have been pulled 




The second section of the pipeline includes the running of the NODDI algorithm. 
This stage can be broken down into several sub-steps described below:  
 
Figure 5: NODDI process 
The first step being the loading of the patient data into memory. This includes the 
NIFTI1 formatted Diffusion Tensor Image resulting from the previous stage, the b-
values, and the b-vectors. The NIFTI1 image format (otherwise shown as nii) is a 
format that provides a wrapper around the image which includes several features. 
Among these features includes the affine related to that image as well as any labels 
or meta data. This type of data was read using the nibabel python package. During 
this loading process the patient’s b-vectors and b-values are read into a gradient table 
through the use of the DIPY package (Garyfallidis et al., 2014). This gradient table 
takes in the locations of the bval and bvec files, loads, and formats them accordingly. 
In this loading there are several quality checks to make sure each are valid.  
Once the nii, bval, and bvec files are loaded the main package utilized then translates 
that gradient table into a scheme for use in the calculation of our model. The scheme 
is utilized from the dmipy package and is the main encapsulation of the data needed 
to simulate and train the model (Fick, Wassermann, & Deriche, 2019). The model 
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utilized in this training step is comprised of three shells: a plane ball model, and a 
Watson dispersed bundle of a stick and zeppelin model. This model comprises the 
Neurite Orientation Dispersion and Density Imaging (NODDI) (Zhang, Schneider, 
Wheeler-Kingshott, & Alexander, 2012). The NODDI model is then fit over the 
entirety of the patient’s brain. The dmipy package includes two main packages for 
performance enhancing: pathos (Michael M. McKerns, 2012; Michael McKerns, 
2010-) and numba.  
Once the model is fitted the resulting parameters are then extracted. The primary 
summary statistic this project focuses on is the ODI values or orientation dispersion 
index. The ODI values are included in a range from 0.0 – 1.0 and are calculated per 
voxel. Through this voxel calculation an image of the brain from these values is 
generated and is then saved using the original diffusion tensor image affine. This 
resulting image has the same properties as the original registered image, allowing us 
to proceed to the post-processing stage.  
Post-Processing 
The proceeding stage after the analysis of the pre-processed images includes several 




Figure 6: Flow Chart of Post-Processing Steps 
The post processing step includes the extraction of the specific tract being studied 
through the use of a mask. For this study we used the cingulum hippocampal tract. 
This tract was pulled from an atlas included in FSL from the Laboratory of Brain 
Anatomical MRI in Johns Hopkins Medical Institute (Hua et al., 2008; Nagae-
Poetscher, 2005; Wakana et al., 2007). This atlas includes a multitude of masks 
built in MNI space. Since the results of our fitted model were calculated in MNI 
space this result can then be utilized to look at specific portions of the brain. Using 
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fslmaths we utilize the atlas related to the cingulum hippocampal region to extract 
the region of interest.  
Once extracted the resulting masked image is then loaded using nibabel and the 
results are then calculated using the masked average value of the region. This 
resulting average is the metric utilized in our statistical study of these trails.  
Modeling 
Once the ODI values are extracted the resulting average of the region specified is 
then added to an excel file that details the patient’s metadata. This metadata 
includes the patient’s RAVLT and MoCA score. Two Linear Regression Models 
are then trained for the use in predicting subjects with MCI.  
The first model includes the mentioned RAVLT and MoCA scores along side the 
ODI values. The values are taken at both intervals and differenced between time 0 
and time 1 (baseline and a 1-year follow-up) then a product is taken between the 
combination of the three differenced categories. The second model then produces 
the same combination but with the exclusion of the ODI values. The second model 
then serves as a benchmark to test the degree with which the inclusion of ODI 
values can help predict MCI subjects. 
Context 
The analysis of the 73 participants (comprising patients and controls) was ran on 
the San Jose State University Spartan01 High Performance Computer. The 
Spartan01 contains 72 compute nodes, 2 high memory nodes, and 4 GPU nodes for 
a combined number of 2152 of compute cores and 23040 GPU cores. The 
Spartan01 runs slurm workload manager. Through Slurm the patients were able to 
be ran concurrently across 5-6 nodes for a total of ~200 individual runs. Each run 
contained ~500 megabytes of data.   
29 
 
In-order to run the patient’s data on the High-Performance Computer (HPC) the 
data first needs to be transferred. The procedure for transferring the data first starts 
with the downloading of the individual patient files from the ADNI server. The 
individual patients contain an average of two years of data. Each year contains 2 
data points: The T1 MRI and the Axial DTI image which are both DICOM 
formatted image files.  
Once downloaded the files require a formatting specific to this implementation 
after the conversion of the DICOM file format to Nifti1 image format. This is done 
by a script written for this purpose. This specific portion of the pipeline requires 
manual work to accomplish. Once the script is run and the files converted to the 
proper format the data must then be uploaded to a server to then be downloaded.  
The server of choice for this implementation is Amazon Web Service’s Simple 
Secure Storage (S3). Once uploaded the files are then downloaded using the 






The first objective of the study is to test two key hypotheses. The first hypothesis is 
that NODDI is sensitive to AD related abnormality and hence NODDI values 
should be higher in controls than in patients with MCI (hypothesis 1). The second 
hypothesis is that if NODDI detects brain degeneration from AD, and MCI patients 
experience brain degeneration over the course of a year, ODI values should 
decrease from baseline to year later (the study of the ability to identify an 
individual with MI using longitudinal data), hypothesis 2. This hypothesis also 
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quantifies the magnitude of that change to identify a target for future therapies. 
What is not known is whether the degeneration is more rapid in patients than 
controls. 
In order to produce data comparative to this situation we focused on patients who 
have been scanned at least two times with the appropriate types (T1 and DTI). This 
gives us a baseline and a year follow up to work with. With this data the null 
hypotheses can be tested. 73 patients were gathered in an even split between those 
diagnosed with control and MCI. 
In summary, we proposed that the null hypothesis in hypothesis 1 is that there 
would be no difference between the control patients and the patients with MCI 
over the period of one year, whereas our alternative hypothesis indicates a 
statistically significant difference. The null hypothesis in hypothesis 2 is that there 
is not a detectable decline over a year. This could occur if timescale is long enough 
to detect a significant change. A secondary analysis may not be long enough to 
measure a significant change. A secondary analysis will examine whether the 
declines are greater in patients with MCI since they are undergoing a degenerative 
process. 
The hypotheses are tested using the results from the NODDI algorithm referred to 
the Orientation Dispersion Index (ODI). ODI measures the dispersion of the axons 
and models, at that voxel, the orientation (be it varying from fanned to highly 
directional). The response variable consists of the a priori diagnosis of each patient 
group (i.e. control or MCI).  
The second objective of our study is to build on the hypothesis that the use of the 
orientation dispersion index can produce group differences and as a result produce 
a predictor that can improve the sensitivity in discriminating patients with mild 
cognitive impairment from controls. 
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The results of each being set through a series of tests in order to produce 
incremental stages which would indicate the possibility of a statistically significant 
declaration.  
The first of these steps being a statistical analysis using an ANCOVA test of the 
variables group (MCI, controls) and time (baseline, year 1). Due to the nature of 
brain degradation and the age differential indicated previously, the inclusion of age 
as a nuisance variable is a must in order to differentiate the group difference being 
purely age.  An interaction of group and time variable tests whether the groups 
differ in change over time. Post hoc analyses should show that the difference 
between the time points should larger in patients with MCI than with controls.  
Once our analysis indicates a statistically significant result, it will be evaluated 
using evaluated accuracy, receiver operating characteristic (ROC), and 
precision/recall values.  
RESULTS  
For our experiment the data gathered was ran through an Analysis of Covariance 
(ANCOVA) with a combination of time point (baseline, year 1) and diagnosis 
group (MCI, controls). A statistically significant t-test confirmed that individuals 
in the MCI group were older than individuals in the control group, age was 
included in the ANOVA as a nuisance variable/covariate. 
Experiment One 
We sought to analyze the differences between the two diagnosis groups. This 
group difference is seen to be the most sensitive. In this case, we sought to confirm 
this through using the ODI values resulting from the NODDI calculation. With 






Repeated Measures Analysis of Variance with Effect Sizes 
and Powers 
 p Observed power (alpha=0.05) 
group 0.000325 0.961 
Table 1: Observed Statistical Power of the Experiment 1 
In the case of the statistical experiment 1 the null hypotheses can be soundly 
rejected with an observed power of 0.961 and a p-value < 0.05. As a result, it can 
be postulated that through NODDI analysis there exists a large difference between 
two groups. As the null hypotheses has been rejected verification can now 
commence.  
The intent of the verification was to interrogate the group difference further. Using 
a regressor we intend to show the predictive power of this group difference. The 
prediction method we selected was a linear regression model. In order to indicate 
practicality, the use of the ODI value of each subject combined with the results 
other tests would prove that the combination could provide an increase in accuracy 
over use without.  
The combination chosen was using the two tests previously described: RAVLT and 
MOCA. A sample size of 140 was produced and a linear regression model was 





Figure 7: Regression Equation of Delta Values 
The combined results produce an accuracy that beats current clinical evaluations 
with RAVLT by itself being 64% (Wood, Moodley, Lever, Minati, & Chan, 2016) 
and MOCA having a specificity of  70-73% (Dautzenberg, Lijmer, & Beekman, 
2020; Masika, Yu, & Li, 2020).  
This equation utilizes a delta for the ODI values, MOCA, and RAVLT over one 
year. Each age variable represents the individual ages of the patients pulled from 
ADNI. Results of this predictor for classification is detailed in table 4. 
Accuracy ROC AUC Average 
Precision 
83.08% 0.98 0.74 
Table 2: Results of Regression Equation with Delta Values 
The results of the model include an increased accuracy as well as an increased 
ROC AUC. The average precision has decreased 0.08. The ROC curve and the 








Figure 9: Recall/Precision for Regression Equation of Delta Values 
In order to verify that this new equation’s accuracy is contributed to the ODI 
values, testing without the ODI values included in the resulting equation resulted in 




Figure 10: Verification Regression Equation without Delta ODI Values 
In this new equation the Delta ODI values was removed, and a new linear 
regression model was trained. The overview of the performance of this model is 
shown in table 5. 
Accuracy ROC AUC Average 
Precision 
78.46% 1.0 0.69 
Table 3: Classification of results on model excluding Delta ODI 
The accuracy has reduced 4.62 percent. The area under the curve has increase 0.02 
and the average precision has decreased 0.05. This result shows a contribution via 








Figure 12: Precision/Recall of Regression Equation without ODI Values 
 
Hypothesis 2: Degeneration 
In the second experiment we sought to confirm a change over time in each 
diagnosis group. Through the use of an ANCOVA we analyzed the effect of both 
time and group and found that the degeneration experienced by the MCI group was 
not of a statistically significant difference of the control group. This resulted in a 







Repeated Measures Analysis of Variance with Effect Sizes 
and Powers 
 P Observed power (alpha=0.05) 
TIME*group 0.306 0.174 
Table 4: Power of Group Differences Over Time 
Our alternative hypothesis states that there was a statically change over time. We 
observed no such change in this cohort. 
 
DISCUSSION 
The most robust finding of our study is that ODI values were lower in patients with 
MCI than those in the control group, confirming hypothesis 1, which states that 
this value is sensitive to abnormality in the medial temporal lobe. A linear 
regression equation further interrogated whether using ODI as a metric improves 
the diagnosis accuracy. The diagnostic ability of the trained classifier was 
evaluated using a ROC curve, accuracy, and average precision. Neither ODI 
change over one year or group differences between ODI changes were statistically 
significant.  
The findings of the study which confirmed hypothesis 1 was validated using linear 
regression. Two models were trained on the dataset generated: one trained with the 
inclusion of the ODI values and one without. Through the inclusion of the ODI 
values, the model showed a marked improvement in accuracy as compared to the 
model trained without.  
CONCLUSION 
Our study demonstrates that NODDI is an excellent method of differentiating 
between the diseased and healthy individuals. Its ability to further characterize the 
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different tissues of the patients allows for a more in-depth and robust analysis of 




Whereas longitudinal change in ODI was too small to detect a future reanalysis of 
data over two or three years may reveal a change. An examination of the raw 
difference scores suggested that the patients with MCI may have experience so 
much decline that their year 1 may reflect a floor effect in which those scores may 
not have farther to fall and the sensitivity of this NODDI analysis may be earlier in 
the disease state. For example, the analysis may be useful in identifying which of 
the healthy controls will later progress.  
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During the RAVLT the examiner reads a list of words and after hearing the list of 
words, the patient needs to repeat those words back. After several trials of this 
immediate recall, there is a 20-minute delay and then the patient is asked to recall 
the items on the list they previously rehearsed.  
RAVLT is broken into two sections: Immediate and Percent Forgetting. A patient’s 
Immediate recall score is the sum of all the items correctly recalled on all the five 
immediate recall trials. The delayed recall is the number of items recalled after this 
delay. An assumption is that with brain atrophy associated with degeneration 
smaller brain regions are associated with worse functioning. This key finding is 
due to the role the medial temporal lobe plays in memory and shows the power of 
RAVLT to indicate a decline in the memory portion of the brain thus providing a 






For reference, a patient classified as one with normal cognition will have a score of 
26 or over. A cut-off score of 18 is considered to this threshold between patients 
with MCI from AD, whereas the average score for MCI is 22 with a range between 
19-25 and 16 for mild AD with a range of 11-21 ("FAQ | MoCA Montreal - 
Cognitive Assessment," 2020). When a more intact level on this range is recorded 
it acts as confirmation that the patient is still at the stage of MCI.  
APPENDIX C 
Grey and White Matter  
Grey matter is comprised of neuron bodies and white matter is comprised of the 
connections between neurons or axons. These white matter brain regions appear to 
be white because the axonal fiber tracts are supported and insulated by glia that 
surround the axons. Much like an electric wire conducts more effectively because 
it is surrounded by insulation, neurons function more effectively when the axons 
that need to conduct brain signals (action potentials) are insulated by glia.  
A white matter fiber tract is a group of axons. The groups travel between different 
brain regions which suggests that there is communication between these brain 
regions. This provides an important clue about how the regions function and how 
brain pathology disrupts this process.  
 
APPENDIX D 
Diffusion Tensor Imaging 
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Diffusion Tensor Imaging processing includes a series of steps of which completes 
with a tensor estimation phase. This phase uses estimation procedures like 
Ordinary Least Squares in order to produce the voxel’s eigenvalues and 
eigenvectors. A voxel’s diffusion tensor represents the base direction and 
magnitude of the voxel at each point in the brain. These directions and magnitudes 
are generated from a 3x3 symmetric matrix.  
Once the tensor is estimated and the brain is modeled, different diffusion 
characteristics are modeled. Of the three tissue types, white matter in the brain is 
characterized by less diffusion restriction but tends to be directionally dependent 
whereas grey matter tends be less directionally dependent. Lastly Cerebral Spinal 
Fluid tends to freely diffuse is every direction. 
These different inherent characteristics of the three tissue types make possible 
modeling tracts and the directions of these voxels over a distance and leading to 
analysis such as tractography that maps entire bundles of axons throughout the 
brain and can give an accurate representation of the internal structure and 
architecture of connections between brain regions.  
Included with the tractography analysis are a variety of summary statistics 
resulting from Diffusion Tensor Imaging. These statistics include two main 
statistics: Mean Diffusivity (MD) and Fractional Anisotropy (FA). Analysis of 
these statistics are usually done in a region of interest manor specifying the area of 
the brain to study. Of these areas, higher MD models an increase of diffusion 
whereas lower FA indicates and lack of cohesion in that region (Soares et al., 
2013). 
APPENDIX E 
Diffusion Compartmental Imaging 
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Diffusion Compartment Imaging is a relatively new subset of techniques to analyze 
Diffusion Weighted Images. DCI’s purpose is to utilize a complex combination of 
different models, each whose purpose is analyzing voxels of different tissue types 
found in the brain of which are divided up into intra-cellular space, extra-cellular 
space (Zhang et al., 2012). 
Extra-cellular space is mostly defined as the cellular membranes of somas and glial 
cells, whereas Intra-cellular space is defined as space bounded by axonal and 
dendritic membranes (Zhang et al., 2012). Each of these cellular types harkens 
back to the two distinctions (free diffusion and restricted diffusion) of the tissues in 
the brain and identifies the different types of restrictions present: Hindered and 
Restricted. Hindered diffusion points to the pattern found in the extra-cellular 
space whereas Restricted diffusion points to the intra-cellular space (Assaf & 
Cohen, 2000).   
The distinction between these two spaces found in Diffusion Weighted Images and 
the types therein produces a model of the brain that is more complex than a 
generalized model of the three types of tissues. In-order to properly analyze this 
distinction a model must include these characteristics, but in what way should 
these distinctions be modeled? 
The Diffusion Tensor Imaging method of modeling is to build a symmetrical 
tensor for each voxel. This symmetrical tensor is modeled with three three-
dimensional vectors representing the directions of flow usually in a single distinct 
direction. This highly specific direction does not consider a possible distribution of 
values over these axes. 
Several implementations have been proposed to provide this distinction to better 
model different types of diffusion in the brain using various shapes. These shapes 
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have their own distributions and characteristics akin to different intra- and extra-
cellular components.  
One such model is the ball and stick model (Behrens et al., 2003). The distinction 
between the intra-cellular and extra-cellular compartments are made using a stick 
and ball representation. The stick, being a cylinder of zero radius, is used to model 
the highly restrictive intra-cellular components, whereas the ball is utilized to 
model the hindered extra-cellular component (Behrens et al., 2003; Panagiotaki et 
al., 2012). Based on the knowledge of the intra-cellular region being highly 
restricted and directional, the stick model portrays this distinction representing 
each voxel to lie on a path that is geometrically restricted. The ball in this case 
portrays the highly diffuse nature of the extra-cellular compartment as the direction 
of diffusion is less strict in these regions.  
Another model named CHARMED or Composite Hindered And Restricted Model 
of Diffusion (CHARMED) utilizes an impermeable ideal cylinder whose radius 
matches a gamma distribution (Assaf & Basser, 2005; Assaf, Freidlin, Rohde, & 
Basser, 2004; Panagiotaki et al., 2012; Zhang et al., 2012). This idealized cylinder 
represents the intra-cellular compartment. The extra-cellular compartment is 
represented by a non-directionally dependent value.  
A simplified version of CHARMED was proposed by Alexander (2008) which 
reduces the complexity of the gamma distribution to a single radius. This keeps the 
form of the cylinder for the intra-cellular representation and a shape of a Zeppelin 
for use in the extra-cellular area. The introduction of the Zeppelin keeps the 
directionally independent nature of the extra-cellular area but introduces a 
symmetric component about an axis. Later additions were made to the CHARMED 
model in the addition of another compartment: free-water. The intent of this 
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compartment was to obtain the minimal model of white matter diffusion coined as 
MMWMD (Barazany, Basser, & Assaf, 2009). 
 
Figure 13: The Stick, Ball, and Zeppelin model 
With each implementation the concept of a distinct shape representing the distinct 
restrictions is paramount. The Ball & Stick method, plus the simplification of the 
CHARMED model with a Zeppelin for the extra-cellular component represents the 
crux of the next model proposed. NODDI or Neurite Orientation Density 
Dispersion Index provides a combination of these models (Zhang et al., 2012).  
In the case of the Intra-cellular model the highly restrictive nature is modeled using 
a Watson distributed distribution of sticks. This allowed for the modeling in 
instances where axons are either highly parallel to other bundles like in the corpus 
callosum to instances where the intra-cellular component consists of fans and 
bends as in the centrum semiovale (Zhang et al., 2012). 
For the extra-cellular model, the compartment is modeled using an orientation-
dispersed cylinder or Zeppelin. The Zeppelin is also modeled using a Watson 
distribution. Lastly, in keeping with the three types of tissues in the brain, the CSF 
or Cerebral Spinal Fluid is modeled using a Ball to represent the lack of directional 
dependence on the count of the diffusion for that region. 
The result of the NODDI calculation, much like DTI, produces a summary 
statistic: Orientation Dispersion Index (ODI). The ODI value consists of a range 
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between 0 and 1 bounded by a Watson distribution which measures the dispersion 
of each voxel’s orientation. A higher ODI value indicates lower diffusion at the 
point of the voxel of which indicate an intact white matter tract. A decrease found 
in ODI would indicate water diffusing more freely due to not being constrained by 
intact white matter tracts and as a result should reflect degeneration.   
Comparisons 
The comparisons between the summary statistic generated by DTI and the ODI 
generated by NODDI was the topic of a recent study by (Wen et al., 2019). This 
study focused on a numerous amount of tract data produced through a cohort of 
patients with no complications to patients with mild cognitive impairment. The key 
contribution taken away from this study was the vast number of tracts studied in 
their analysis. The study contained an analysis of 27 tracks of patients with early-
stage Alzheimer’s disease. Of these tracks Wen et al. (2019) found that the tracks 
with the highest predictive power to discriminate groups were found in the 
parahippocampal cingulum, thalamic radiation, and forceps major region of the 
brain.  
An addition comparison between DTI, NODDI, and q-space analysis resulted with 
DTI being the most sensitive in its ability to produce a characterization of the 
degradation but found that NODDI and q-space still characterized the degradation.  
With the a-priori analysis produced by Wen et al. (2019) we proceed with an 
analysis of a variety of patients of which include an even distribution of control 
and those diagnosed with MCI the goal of which is to utilize RAVLT and MOCA 
as well as NODDI to produce a group difference between the two that is invariant 
to possible attributes like age.  
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